| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 72 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 67 |
| 2 | TACROLIMUS OINTMENT 0.1% | 67 |
| 3 | PREDNISONE | 52 |
| 4 | MYCOPHENOLATE MOFETIL | 44 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 44 |
| 6 | METHYLPREDNISOLONE | 36 |
| 7 | VORICONAZOLE | 29 |
| 8 | VORICONAZOLE INJECTION | 29 |
| 9 | PREDNISOLONE | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 6 | 0.0042 |
| 1 | PENCICLOVIR | 1 | 0.0028 |
| 2 | DAPTOMYCIN | 15 | 0.0016 |
| 3 | AMPHOTERICIN B | 20 | 0.0016 |
| 4 | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | 1 | 0.0014 |
| 5 | AMPHOTERICIN B LIPOSOME | 3 | 0.0013 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 10 | 0.0012 |
| 7 | DEXRAZOXANE FOR INJECTION | 1 | 0.0011 |
| 8 | VORICONAZOLE | 29 | 0.0009 |
| 9 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 107 |
| 1 | Azole Antifungal [EPC] | 48 |
| 2 | Polyene Antifungal [EPC] | 24 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 23 |
| 4 | Lipopeptide Antibacterial [EPC] | 15 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 6 | Insulin Analog [EPC] | 11 |
| 7 | Alkylating Drug [EPC] | 10 |
| 8 | Glycopeptide Antibacterial [EPC] | 10 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 6 | 0.0042 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 23 | 0.0018 |
| 2 | Lipopeptide Antibacterial [EPC] | 15 | 0.0016 |
| 3 | Interferon gamma [EPC] | 1 | 0.0007 |
| 4 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 5 | Polyene Antifungal [EPC] | 24 | 0.0006 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 9 | 0.0004 |
| 7 | Azole Antifungal [EPC] | 48 | 0.0003 |
| 8 | Allylamine Antifungal [EPC] | 2 | 0.0003 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |